newsfilter
← Latest News
FDA Approved Drugs·

Approval of Ingrezza, Nda #209241 (Labeling)

Approval Date: 10/23/2026; Drug Name: Ingrezza, Nda #209241; Active Ingredients: VALBENAZINE TOSYLATE; Company: Neurocrine; Submission Status: Approval; Submission Classification: Labeling; Application Number: 209241

Company
NEUROCRINE
Keywords
NEUROCRINE